Serina Therapeutics (SER) EBIT Growth (3y) (2021 - 2026)
Serina Therapeutics (SER) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 6.70% |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 8.36% |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 69.02% |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 24.14% |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 44.54% |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 44.34% |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -28.30% |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 81.27% |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | -18.82% |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | -92.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -92.91% |
| Dec 31, 2025 | -51.59% |
| Sep 30, 2025 | -60.36% |
| Jun 30, 2025 | -51.80% |
| Mar 31, 2025 | -41.86% |
| Dec 31, 2024 | -43.78% |
| Sep 30, 2024 | -46.95% |
| Jun 30, 2024 | -20.58% |
| Mar 31, 2024 | -2.00% |
| Dec 31, 2023 | 28.13% |
| Sep 30, 2023 | 15.17% |
| Jun 30, 2023 | 26.38% |
| Mar 31, 2023 | 31.61% |
| Dec 31, 2022 | 13.11% |
| Sep 30, 2022 | 22.10% |
| Jun 30, 2022 | 22.68% |
| Mar 31, 2022 | 13.05% |
| Dec 31, 2021 | 17.77% |
| Sep 30, 2021 | 8.73% |
| Jun 30, 2021 | -1.10% |